Changes in the DNA of cells cause cancer. Cancer genomics identifies genetic changes, defines molecular subtypes, and develops precision medicine techniques for cancer treatment using technologies such as sequencing. Genome sequencing is providing physicians greater information about the causes of cancer and modifying how some cancers are treated. Genomic assays allow for the identification of somatic and germline abnormalities in individual tumor samples, are becoming more widely employed in clinical diagnostics as a means of determining therapeutic alternatives. Genomic-based tests are increasingly being used as part of evidence-based diagnosis to help patients with cancer get better care.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States